Glycaemia and correlates of patient-reported outcomes in ACCORD trial participants

Diabetic Medicine

Volumn 29, Issue 7, 2012, Pages

  Ali, M K ^a   Feeney, P ^b,c   Hire, D ^b   Simmons, D L ^d   O'Connor, P J ^e   Ganz Lord, F ^f   Goff, D ^g   Zhang, P ^h   Anderson, R T ⁱ   Narayan, K M V ^a   Sullivan, M D ^j  

^a EMORY UNIVERSITY   (United States)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^c University of Iowa   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g WAKE FOREST SCHOOL OF MEDICINE   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

ⁱ PENNSYLVANIA STATE UNIVERSITY   (United States)

^j UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

more..

Author keywords

ACCORD study; Cardiovascular disease; Health related quality of life; Patient reported outcomes; Type 2 diabetes

Indexed keywords

ANTIHYPERTENSIVE AGENT; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; HYPOGLYCEMIA; INSULIN TREATMENT; KIDNEY FAILURE; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MICROALBUMINURIA; PATIENT SATISFACTION; PERIPHERAL NEUROPATHY; QUALITY OF LIFE; SHORT FORM 36; WEIGHT CHANGE;

ADULT; AGED; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MENTAL HEALTH; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84862658856     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03532.x     Document Type: Article

References (31)

1. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-2559.
2. Sullivan MD, Anderson RT, Aron D, Atkinson HH, Bastien A, Chen GJ et al. Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: rationale and design. Am J Cardiol 2007; 99: 90i-102i.
3. Testa MA, Simonson DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial. JAMA 1998; 280: 1490-1496.
4. Goddijn PPM, Bilo HJG, Feskens EJM, Groenier KH, van der Zee KI, Meyboom-de Jong B. Longitudinal study on glycaemic control and quality of life in patients with Type 2 diabetes mellitus referred for intensified control. Diabetic Med 1999; 16: 23-30.
5. Weinberger M, Kirkman MS, Samsa GP, Cowper PA, Shortliffe EA, Simel DL et al. The relationship between glycemic control and health-related quality of life in patients with non-insulin-dependent diabetes mellitus. Med Care 1994; 32: 1173-1181.
6. Tabaei BP, Shill-Novak J, Brandle M, Burke R, Kaplan RM, Herman WH. Glycemia and the quality of well-being in patients with diabetes. Qual Life Res 2004; 13: 1153-1161.
7. Adriaanse MC, Pouwer F, Dekker JM, Nijpels G, Stehouwer CD, Heine RJ et al. Diabetes-related symptom distress in association with glucose metabolism and comorbidity: the Hoorn Study. Diabetes Care 2008; 31: 2268-2270.
8. Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care 2002; 25: 458-463.
9. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev 1999; 15: 205-218.
10. Van der Does FE, De Neeling JN, Snoek FJ, Kostense PJ, Grootenhuis PA, Bouter LM et al. Symptoms and well-being in relation to glycemic control in type II diabetes. Diabetes Care 1996; 19: 204-210.
11. Gore M, Brandenburg NA, Dukes E, Hoffman DL, Tai KS, Stacey B. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage 2005; 30: 374-385.
12. Fincke BG, Clark JA, Linzer M, Spiro A 3rd, Miller DR, Lee A et al. Assessment of long-term complications due to type 2 diabetes using patient self-report: the diabetes complications index. J Ambul Care Manage 2005; 28: 262-273.
13. Pitale S, Kernan-Schroeder D, Emanuele N, Sawin C, Sacks J, Abraira C. Health-related quality of life in the VA Feasibility study on glycemic control and complications in type 2 diabetes mellitus. J Diabetes Complications 2005; 19: 207-211.
14. UK Prospective Diabetes Study Group. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care 1999; 22: 1125-1136.
15. Speight J, Reaney M, Barnard K. Not all roads lead to Rome - a review of quality of life measurement in adults with diabetes. Diabet Med 2009; 26: 315-327.
16. Peyrot M, Rubin RR. How does treatment satisfaction work? Modeling determinants of treatment satisfaction and preference. Diabetes Care 2009; 32: 1411-1417.
17. Buse JB, Bigger JT, Byington RP, Cooper LS, Cushman WC, Friedewald WT et al. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol 2007; 99: 21i-33i.
18. Anderson RT, Narayan KM, Feeney P, Goff D Jr, Ali MK, Simmons DL et al. Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trial. Diabetes Care 2011; 34: 807-812.
19. Unden AL, Elofsson S, Andreasson A, Hillered E, Eriksson I, Brismar K. Gender differences in self-rated health, quality of life, quality of care, and metabolic control in patients with diabetes. Gend Med 2008; 5: 162-180.
20. Wexler DJ, Grant RW, Wittenberg E, Bosch JL, Cagliero E, Delahanty L et al. Correlates of health-related quality of life in type 2 diabetes. Diabetologia 2006; 49: 1489-1497.
21. Rejeski WJ, Lang W, Neiberg RH, Van Dorsten B, Foster GD, Maciejewski ML et al. Correlates of health-related quality of life in overweight and obese adults with type 2 diabetes. Obesity (Silver Spring) 2006; 14: 870-883.
22. Glasgow RE, Ruggiero L, Eakin EG, Dryfoos J, Chobanian L. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care 1997; 20: 562-567.
23. Hermansen K, Mortensen LS. Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus. Drug Saf 2007; 30: 1127-1142.
24. Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial. Diabetes Care 1996; 19: 195-203.
25. Janssen PG, Gorter KJ, Stolk RP, Rutten GE. Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION Netherlands study. Br J Gen Pract 2009; 59: 43-48.
26. Pouwer F, Snoek FJ, van der Ploeg HM, Ader HJ, Heine RJ. Monitoring of psychological well-being in outpatients with diabetes: effects on mood, HbA(1c), and the patient's evaluation of the quality of diabetes care: a randomized controlled trial. Diabetes Care 2001; 24: 1929-1935.
27. de Wit M, Delemarre-van de Waal HA, Bokma JA, Haasnoot K, Houdijk MC, Gemke RJ et al. Monitoring and discussing health-related quality of life in adolescents with type 1 diabetes improve psychosocial well-being: a randomized controlled trial. Diabetes Care 2008; 31: 1521-1526.
28. Testa MA, Simonson DC. Assesment of quality-of-life outcomes. N Engl J Med 1996; 334: 835-840.
29. Anderson RM, Funnell MM, Butler PM, Arnold MS, Fitzgerald JT, Feste CC. Patient empowerment. Results of a randomized controlled trial. Diabetes Care 1995; 18: 943-949.
30. Nicolucci A, Cucinotta D, Squatrito S, Lapolla A, Musacchio N, Leotta S et al. Clinical and socio-economic correlates of quality of life and treatment satisfaction in patients with type 2 diabetes. Nutr Metab Cardiovasc Dis 2009; 19: 45-53.
31. Peyrot M, Rubin RR. Structure and correlates of diabetes-specific locus of control. Diabetes Care 1994; 17: 994-1001.